Us3 kinase encoded by herpes simplex virus 1 mediates downregulation of cell surface major histocompatibility complex class I and evasion of CD8+ T cells

PLoS One. 2013 Aug 12;8(8):e72050. doi: 10.1371/journal.pone.0072050. eCollection 2013.

Abstract

Detection and elimination of virus-infected cells by CD8(+) cytotoxic T lymphocytes (CTLs) depends on recognition of virus-derived peptides presented by major histocompatibility complex class I (MHC-I) molecules on the surface of infected cells. In the present study, we showed that inactivation of the activity of viral kinase Us3 encoded by herpes simplex virus 1 (HSV-1), the etiologic agent of several human diseases and a member of the alphaherpesvirinae, significantly increased cell surface expression of MHC-I, thereby augmenting CTL recognition of infected cells in vitro. Overexpression of Us3 by itself had no effect on cell surface expression of MHC-I and Us3 was not able to phosphorylate MHC-I in vitro, suggesting that Us3 indirectly downregulated cell surface expression of MHC-I in infected cells. We also showed that inactivation of Us3 kinase activity induced significantly more HSV-1-specific CD8(+) T cells in mice. Interestingly, depletion of CD8(+) T cells in mice significantly increased replication of a recombinant virus encoding a kinase-dead mutant of Us3, but had no effect on replication of a recombinant virus in which the kinase-dead mutation was repaired. These results indicated that Us3 kinase activity is required for efficient downregulation of cell surface expression of MHC-I and mediates evasion of HSV-1-specific CD8(+) T cells. Our results also raised the possibility that evasion of HSV-1-specific CD8(+) T cells by HSV-1 Us3-mediated inhibition of MHC-I antigen presentation might in part contribute to viral replication in vivo.

MeSH terms

  • Animals
  • Antigen Presentation / immunology
  • Antigens, Viral / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / metabolism*
  • CD8-Positive T-Lymphocytes / virology*
  • Cell Line
  • Cell Membrane / metabolism
  • Chlorocebus aethiops
  • Enzyme Activation
  • Female
  • Gene Order
  • Genome, Viral
  • Herpesvirus 1, Human / genetics
  • Herpesvirus 1, Human / immunology
  • Herpesvirus 1, Human / metabolism*
  • Histocompatibility Antigens Class I / genetics
  • Histocompatibility Antigens Class I / immunology
  • Histocompatibility Antigens Class I / metabolism*
  • Humans
  • Killer Cells, Natural / immunology
  • Lymphocyte Depletion
  • Mice
  • Mutation
  • Phosphorylation
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • T-Lymphocytes, Cytotoxic / immunology
  • Vero Cells
  • Viral Proteins / genetics
  • Viral Proteins / metabolism*
  • Virus Replication / genetics
  • Virus Replication / immunology

Substances

  • Antigens, Viral
  • Histocompatibility Antigens Class I
  • Viral Proteins
  • Protein Serine-Threonine Kinases
  • US3 protein, Human herpesvirus 1

Grants and funding

This study was supported by the Funding Program for Next Generation World-Leading Researchers and Grants for Scientific Research from the Japan Society for the Promotion of Science (JSPS), a contract research fund for the Program of Japan Initiative for Global Research Network on Infectious Diseases and Global COE Program “Center of Education and Research for the Advanced Genome-Based Medicine -For personalized medicine and the control of worldwide infectious diseases-” from the Ministry of Education, Culture, Science, Sports and Technology of Japan, and grants from the Takeda Science Foundation, the Naito Foundation, the Sumitomo Foundation, the Waksman Foundation of Japan and the Tokyo Biochemical Research Foundation. TI was supported by research fellowships from JSPS for Young Scientists and from Nippon Institute for Biological Science and AS was supported by a research fellowships from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.